A grandfather says he took Ozempic for weight loss and now lives with partial blindness, claiming he was not adequately warned about the risk. He is one of more than 200 people who have brought legal action against Novo Nordisk in the United States.
The outlets frame the case similarly, focusing on the same allegation: that use of the weight-loss injection has resulted in sight problems. The Mirror also emphasizes the claimant’s background and his assertion that, had he known about potential vision loss, he would not have taken the medicine. The Manchester Evening News leads with the broader number of plaintiffs and presents the lawsuit as a group action rather than centering solely on one individual.
